ISRCTN08988781已完成未知
A multicentre randomised controlled trial to improve communication with patients about clinical trials within cancer teams
Brighton and Sussex Medical School (UK)0 个研究点目标入组 1,600 人开始时间: 2010年3月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,600
研究概览
简要总结
2013 Results article in http://www.ncbi.nlm.nih.gov/pubmed/23403074 results
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Cancer teams working in Wales
- •2. Patients who have had a randomised clinical trial discussed with them by one of the team members
- •3. Either sex, aged 18 - 90 years
排除标准
- •Cancer teams in other parts of the UK
研究者
相似试验
已完成
2 期
A randomised open-labelled multicentre trial of the efficacy of epirubicin, oxaliplatin and capecitabine (EOX) with or without panitumumab in previously untreated advanced oesophago-gastric cancerAdvanced oesophago-gastric cancerOesophago-gastric cancerCancerISRCTN65080435The Royal Marsden Hospital NHS Foundation Trust (UK)553
已完成
3 期
Suppression of Ovarian Function TrialCancerBreast cancerISRCTN73368402European Institute of Oncology (IEO) (Italy)3,066
已完成
3 期
Kids In Control OF Food (KICk-OFF)DiabetesISRCTN37042683Sheffield Children's NHS Foundation Trust (UK)576
已完成
3 期
A phase III multi-centre randomised controlled trial to assess whether optimal supportive care alone (including dexamethasone) is as effective as optimal supportive care (including dexamethasone) plus whole brain radiotherapy in the treatment of patients with inoperable brain metastases from non-small cell lung canceron-small cell lung cancer with inoperable brain metastasesLung cancerCancerISRCTN13826061Medical Research Council (MRC) (UK)534
已完成
不适用
A randomised, open-label, multicentre, efficacy and safety study examining the effects on viral kinetics of all-trans retinoic acid (Tretinoin) (VESANOID®) in combination with pegylated interferon alpha-2a (PEGASYS®) and ribavirin (COPEGUS®) therapy in patients with genotype 1-chronic hepatitis C and non-response to a previous course of peg-interferon alpha/ribavirin combination (ATRACTION)Hepatitis CISRCTN00680126Johannes Gutenberg-University Mainz (Johannes Gutenberg-Universitat Mainz) (Germany)57